- Home
- INM vs SPRC Comparison
INM vs SPRC Comparison
Compare INM & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- SPRC
- Stock Information
- Founded
- INM 1981
- SPRC 2004
- Country
- INM Canada
- SPRC Israel
- Employees
- INM N/A
- SPRC N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- SPRC Health Care
- Exchange
- INM Nasdaq
- SPRC Nasdaq
- Market Cap
- INM 4.1M
- SPRC 4.3M
- IPO Year
- INM N/A
- SPRC N/A
- Fundamental
- Price
- INM $1.70
- SPRC $2.52
- Analyst Decision
- INM
- SPRC
- Analyst Count
- INM 0
- SPRC 0
- Target Price
- INM N/A
- SPRC N/A
- AVG Volume (30 Days)
- INM 61.5K
- SPRC 173.6K
- Earning Date
- INM 11-06-2025
- SPRC 01-01-0001
- Dividend Yield
- INM N/A
- SPRC N/A
- EPS Growth
- INM N/A
- SPRC N/A
- EPS
- INM N/A
- SPRC N/A
- Revenue
- INM $4,798,116.00
- SPRC $1,306,000.00
- Revenue This Year
- INM N/A
- SPRC N/A
- Revenue Next Year
- INM N/A
- SPRC N/A
- P/E Ratio
- INM N/A
- SPRC N/A
- Revenue Growth
- INM N/A
- SPRC N/A
- 52 Week Low
- INM $1.56
- SPRC $1.75
- 52 Week High
- INM $8.27
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- INM 36.70
- SPRC 33.85
- Support Level
- INM $1.59
- SPRC $2.68
- Resistance Level
- INM $1.91
- SPRC $2.82
- Average True Range (ATR)
- INM 0.10
- SPRC 0.21
- MACD
- INM 0.00
- SPRC -0.07
- Stochastic Oscillator
- INM 29.47
- SPRC 3.09
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.